loadpatents
name:-0.027540922164917
name:-0.014959096908569
name:-0.0068290233612061
LeBowitz; Jonathan Patent Filings

LeBowitz; Jonathan

Patent Applications and Registrations

Patent applications and USPTO patent grants for LeBowitz; Jonathan.The latest application filed is for "hydrophobic peptide salts for extended release compositions".

Company Profile
6.21.27
  • LeBowitz; Jonathan - Novato CA
  • LeBowitz; Jonathan - Whitefish Bay WI
  • LeBowitz; Jonathan - Frontenac MO
  • LeBowitz; Jonathan - Zionsville IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hydrophobic Peptide Salts for Extended Release Compositions
App 20220280647 - Ang; Jake ;   et al.
2022-09-08
Lysosomal targeting peptides and uses thereof
Grant 11,351,231 - LeBowitz , et al. June 7, 2
2022-06-07
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
App 20220127326 - Aoyagi-Scharber; Mika ;   et al.
2022-04-28
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
Grant 11,254,725 - Aoyagi-Scharber , et al. February 22, 2
2022-02-22
Lysosomal Targeting Peptides and Uses Thereof
App 20210069304 - LeBowitz; Jonathan ;   et al.
2021-03-11
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
App 20190225666 - Aoyagi-Scharber; Mika ;   et al.
2019-07-25
Targeted Therapeutic Proteins
App 20190224282 - LeBowitz; Jonathan ;   et al.
2019-07-25
Targeted therapeutic proteins
Grant 10,300,113 - LeBowitz , et al.
2019-05-28
Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
Grant 10,301,369 - Aoyagi-Scharber , et al.
2019-05-28
Lysosomal Targeting Peptides and Uses Thereof
App 20180125949 - LeBowitz; Jonathan ;   et al.
2018-05-10
Targeted Therapeutic Proteins
App 20180055911 - LeBowitz; Jonathan ;   et al.
2018-03-01
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
Grant 9,845,346 - Aoyagi-Scharber , et al. December 19, 2
2017-12-19
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
App 20170355744 - AOYAGI-SCHARBER; MIKA ;   et al.
2017-12-14
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
Grant 9,834,588 - Aoyagi-Scharber , et al. December 5, 2
2017-12-05
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
Grant 9,834,587 - Aoyagi-Scharber , et al. December 5, 2
2017-12-05
Targeted therapeutic proteins
Grant 9,814,762 - LeBowitz , et al. November 14, 2
2017-11-14
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
Grant 9,771,408 - Aoyagi-Scharber , et al. September 26, 2
2017-09-26
Lysosomal Targeting Peptides and Uses Thereof
App 20170007680 - LeBowitz; Jonathan ;   et al.
2017-01-12
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
Grant 9,376,480 - Aoyagi-Scharber , et al. June 28, 2
2016-06-28
Targeted Therapeutic Proteins
App 20160152680 - LeBowitz; Jonathan ;   et al.
2016-06-02
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
App 20160039900 - Aoyagi-Scharber; Mika ;   et al.
2016-02-11
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
App 20160031964 - Aoyagi-Scharber; Mika ;   et al.
2016-02-04
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
App 20160031965 - Aoyagi-Scharber; Mika ;   et al.
2016-02-04
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
App 20160031963 - Aoyagi-Scharber; Mika ;   et al.
2016-02-04
Targeted Therapeutic Proteins
App 20150064183 - LeBowitz; Jonathan ;   et al.
2015-03-05
Targeted therapeutic proteins
Grant 8,859,498 - LeBowitz , et al. October 14, 2
2014-10-14
Formulations for lysosomal enzymes
Grant 8,785,168 - LeBowitz , et al. July 22, 2
2014-07-22
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
App 20140161788 - Aoyagi-Scharber; Mika ;   et al.
2014-06-12
Targeted Therapeutic Proteins
App 20140056867 - LeBowitz; Jonathan ;   et al.
2014-02-27
Lysosomal targeting peptides and uses thereof
Grant 8,563,691 - LeBowitz , et al. October 22, 2
2013-10-22
Targeted therapeutic proteins
Grant 8,492,337 - LeBowitz , et al. July 23, 2
2013-07-23
Targeted therapeutic proteins
Grant 8,492,338 - LeBowitz , et al. July 23, 2
2013-07-23
Formulations for Lysosomal Enzymes
App 20120148556 - LeBowitz; Jonathan ;   et al.
2012-06-14
Methods for Treating Pompe Disease
App 20120093794 - LeBowitz; Jonathan ;   et al.
2012-04-19
Methods and compositions for targeting proteins across the blood brain barrier
Grant 7,981,864 - LeBowitz July 19, 2
2011-07-19
Acid alpha-glucosidase and fragments thereof
Grant 7,785,856 - LeBowitz , et al. August 31, 2
2010-08-31
Methods for treating pompe disease
App 20090117091 - LeBowitz; Jonathan ;   et al.
2009-05-07
Acid alpha-glucosidase and fragments thereof
App 20080299640 - LeBowitz; Jonathan ;   et al.
2008-12-04
Methods and Compositions for Targeting Proteins Across the Blood Brain Barrier
App 20080241118 - LeBowitz; Jonathan
2008-10-02
Methods and compositions for targeting proteins across the blood brain barrier
App 20060121018 - LeBowitz; Jonathan
2006-06-08
Nuclear factors associated with transcriptional regulation
App 20060063709 - Baltimore; David ;   et al.
2006-03-23
Acid alpha-glucosidase and fragments thereof
App 20050244400 - LeBowitz, Jonathan ;   et al.
2005-11-03
Methods and compositions for targeting proteins across the blood brain barrier
App 20030072761 - LeBowitz, Jonathan
2003-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed